Bgm Group Ltd Asset Turnover Ratio (BGM), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bgm Group Ltd  (BGM)
 

Bgm Group Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2024, Bgm Group Ltd's asset turnover ratio sequentially decreased to 0.13 in the fourth quarter (Sep 30 2024), this is lower than usual.

Within sector 31 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2024 compared to the preceding quarter from 718 to 748.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BGM Asset Turnover Ratio (Sep 30 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Asset Change 662.74 % 385.5 % 8.68 % 19.62 % 8.68 %
Y / Y Revenue Change -47.29 % - - - -29.46 %
Asset Turnover Ratio (TTM) 0.13 - - - 0.94
BGM's Total Ranking # 748 # 718 # 0 # 0 # 0
Seq. Asset Change 107.29 % 267.96 % 10.3 % -9.34 % 31.95 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 74
Overall Market # 748

Asset Turnover Ratio Statistics
High Average Low
32.94 24.28 15.63
(Sep 30 2021)   (Sep 30 2024)




BGM Company Profile • Back to BGM Efficiency Comparisons • Compare BGM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Aclaris Therapeutics Inc   0.15 $ 27.080  Millions$ 178.734  Millions
Zevra Therapeutics Inc   0.15 $ 24.786  Millions$ 164.892  Millions
Editas Medicine Inc   0.15 $ 61.758  Millions$ 412.967  Millions
Petros Pharmaceuticals inc   0.15 $ 4.098  Millions$ 27.493  Millions
Regenxbio Inc   0.15 $ 84.327  Millions$ 572.920  Millions
Vaxart Inc   0.15 $ 16.760  Millions$ 115.231  Millions
Lucid Diagnostics Inc   0.14 $ 4.189  Millions$ 29.007  Millions
Neurometrix Inc   0.14 $ 2.814  Millions$ 19.552  Millions
Sage Therapeutics Inc   0.14 $ 106.398  Millions$ 742.354  Millions
Eyepoint Inc   0.14 $ 45.713  Millions$ 327.399  Millions
Ginkgo Bioworks Holdings Inc   0.14 $ 217.951  Millions$ 1,588.310  Millions
Ocular Therapeutix Inc   0.14 $ 61.442  Millions$ 449.617  Millions
Cartesian Therapeutics Inc   0.13 $ 47.938  Millions$ 358.328  Millions
Nurix Therapeutics Inc   0.13 $ 56.424  Millions$ 423.226  Millions
Royalty Pharma Plc  0.13 $ 2,266.003  Millions$ 17,052.889  Millions
Hyperfine Inc   0.13 $ 10.751  Millions$ 81.410  Millions
Prophase Labs Inc   0.13 $ 12.087  Millions$ 91.861  Millions
Arvinas Inc   0.13 $ 161.100  Millions$ 1,240.975  Millions
Anaptysbio Inc   0.13 $ 57.172  Millions$ 444.755  Millions
Skinvisible Inc   0.13 $ 0.020  Millions$ 0.157  Millions
Tff Pharmaceuticals Inc  0.13 $ 1.282  Millions$ 10.161  Millions
Pavmed Inc   0.12 $ 4.383  Millions$ 35.084  Millions
Kamada Ltd   0.12 $ 41.740  Millions$ 350.082  Millions
Xencor Inc  0.12 $ 108.666  Millions$ 925.627  Millions
Zymeworks Inc   0.12 $ 62.199  Millions$ 534.355  Millions
Inspiremd Inc   0.12 $ 5.676  Millions$ 48.953  Millions
Cyclo Therapeutics Inc   0.11 $ 0.871  Millions$ 7.596  Millions
Hcw Biologics Inc   0.11 $ 3.215  Millions$ 28.079  Millions
Tango Therapeutics Inc   0.11 $ 43.384  Millions$ 385.664  Millions
Zomedica Corp   0.11 $ 25.965  Millions$ 232.724  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.